One reason given for proactive participation and earlier submission of a monograph was the possibility of prospective or informal harmonization across multiple pharmacopoeias. It is instructive to ...

This session, describing harmonized regulations and standards-setting in other sectors, offered two in-depth reports. The first was a look at international harmonization efforts for a completely ...

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation. More than 20 years after three of the world's largest pharmacopeias joined forces to work on harmonizing ...